-+ 0.00%
-+ 0.00%
-+ 0.00%

ST Wanbang (002082.SZ) subsidiary product Huperzine A injection was selected and purchased by an inter-provincial alliance

Zhitongcaijing·08/11/2026 08:25:02
Listen to the news

Zhitong Finance App News, ST Wanbang (002082.SZ) issued an announcement. Wanbond Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary of the company, participated in the bidding process led by Henan Province to carry out centralized procurement work for 34 drugs. According to the “34 Drugs Provincial Alliance Procurement Notice (8)” issued by the “34 Drugs Provincial Alliance Procurement Office” on August 10, 2026, the company's product, Hysanzine Alkyl Injection, was selected for this procurement.

According to reports, huxerine A injection is suitable for benign memory disorders, improving patients' ability to point memory, associative learning, image recall, meaningless graphics, and recall portraits; for dementia patients and memory impairment caused by organic brain lesions. The current selection will help target the agreed procurement volume of public hospitals within the alliance, further expand the sales scale of the selected products, and increase the national market share of huxerzine A injections in the treatment of cognitive impairment and myasthenia gravis.